Velusetrag not checked
Alfasigma S.p.A. · TD-5108
FollowEvery change as it happens, and a Monday email
Stage
No active trials
Next date
None yet
Trials
0 active
3 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Subjects will be randomly allocated in a blinded fashion to 1 out of the 4 treatment sequences (each sequence include 4 periods, 2 periods with velusetrag and 2 periods with placebo). There will be a wash-out period between each treatment period.”In the company’s words, NCT05724069 on ClinicalTrials.gov
- Tested for
- Chronic Intestinal Pseudo-obstruction, Chronic Constipation, Alzheimer's Disease
- Main trialPhase 2
- “This is a phase II, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of velusetrag once a day, compared to placebo, in subjects with CIPO.”In the company’s words, NCT05724069 on ClinicalTrials.gov
- Other names
- TD-5108
Other drugs for Chronic Constipation
- BrenipatideEli Lilly · Phase 2
- PlecanatideBausch Health Americas, Inc. · Phase 2
- NaldemedineShionogi · Phase 1/2
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials3
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Completed | 12 Apr 2023 | Velusetrag for the Treatment of Chronic Intestinal Pseudo-Obstruction (CIPO). | |
| Phase 2Completed | not given | Evaluate the Safety and Efficacy of a 5-HT4 Agonist in Chronic Constipation (ACCORD Trial) | |
| Phase 1Completed | Jan 2012 | Safety, Pharmacokinetics and Pharmacodynamics of Velusetrag in Healthy Elderly Subjects |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026